Varenicline Tablet, Film Coated
Product Images NDC 0904-7414

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Varenicline (NDC 0904-7414). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Var 0 5mg)

Label (Var 0 5mg)
Label for Major Pharmaceuticals varenicline tablets, film coated, available in strengths including 0.5 mg. The label states dosage form as oral tablets and includes storage instructions with temperature ranges and handling precautions. It displays the NDC 0904-7413-35 and indicates package contains 56 tablets. The label includes manufacturer and distributor details and a note to always dispense with a medication guide.*
FDA Label Image

Label (Var 1mg)

Label (Var 1mg)
Varenicline Tablets 1 mg film-coated oral tablets by Major Pharmaceuticals. The label specifies 56 tablets in the package and includes directions to always dispense with a medication guide. It lists storage instructions and manufacturer information, along with an NDC barcode. The label denotes the product as prescription only.*
FDA Label Image

Var-fig-1 (Var Fig 1)

Var-fig-1 (Var Fig 1)
A grouped bar chart showing percentage outcomes for studies 2 through 5 comparing varenicline 0.5 mg BID, varenicline 1.0 mg BID, varenicline flexible, bupropion SR 150 mg BID, and placebo. Each study compares different dosing or treatments versus placebo with error bars displayed on each bar.*
FDA Label Image

Var-fig-2 (Var Fig 2)

Var-fig-2 (Var Fig 2)
A bar chart comparing four different treatment groups and placebo across four separate studies (Study 2, Study 3, Study 4, Study 5). The y-axis represents a percentage range from 0% to 35%, with treatment groups including varying doses of varenicline and bupropion, and placebo as controls. Each study panel shows treatment effects with error bars indicating variability.*
FDA Label Image

Varenicline Tablets (Var St Pack)

Varenicline Tablets (Var St Pack)
Packaging label for Major Pharmaceuticals Varenicline Tablets Starting Pack in 0.5 mg and 1 mg oral film-coated tablets. The 53-tablet pack includes a 1-week supply of 0.5 mg tablets and 3 weeks of 1 mg tablets. Label notes dosage instructions and storage information.*
FDA Label Image

Var01 (Var01)

Var01 (Var01)
Chemical structure of varenicline tartrate, showing its molecular composition with a bicyclic structure and a tartrate component.*
FDA Label Image

Var04 (Var04)

Var04 (Var04)
A line graph comparing the percentage of continuous abstinent individuals over time between Varenicline 1 mg tablets taken twice daily and a placebo. The x-axis shows nontreatment follow-up in weeks, while the y-axis indicates the percentage continuously abstinent from 0 to 100%. Two lines represent the Varenicline 1.0 mg BID group and the placebo group, showing a higher abstinence percentage in the Varenicline group throughout the follow-up period.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.